RnRMarketResearch offers "Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018" global research report in its store.
The animal antimicrobials and antibiotics market was valued at $3,340.8 million in 2013 and is expected to grow at a modest CAGR of 4.4% from 2013 to 2018. North America dominated the animal antimicrobials and antibiotics market in 2013. However, the market share of this region will decrease to 27%, primarily due to the regulatory ban on the use of antibiotics announced in the U.S. At the same time, Asia and Latin America are poised to grow at a CAGR of 6% to 8% in the forecast period; this growth is largely driven by the increased urbanization, rising disposable incomes, increase in the demand for animal products and the increasing trend of pet ownerships in these regions. Regulatory ban on usage of antibiotics, growing antibiotic resistance, dearth of new antibiotics in pharmaceutical companies pipeline are major factors curbing the growth of these animal antimicrobials and antibiotics markets.
The major players in the animal antimicrobials and antibiotics market are Zoetis, Inc., Merck And Co., Inc., Bayer Ag, Virbac Sa, Eli Lilly And Company, Boehringer Ingelheim, Sanofi, Novartis Ag, Ceva Sante Animale, and Vetoquinol. Complete report is available at http://www.rnrmarketresearch.com/animal-antimicrobials-and-antibiotics-market-by-products-tetracyclines-penicillins-sulfonamides-aminoglycosides-animals-dog-poultry-swine-mode-of-delivery-premixes-oral-powders-and-soluti-market-report.html .
At present, the global antimicrobials and antibiotics market is driven by the growing need to preserve animal health owing to rising demand for animal proteins across the globe, and growing demand in the companion animals segment. Growing livestock population, increasing incidences of disease outbreaks and increase in the companion animal ownership are some of the factors driving the growth of this market to a certain extent. Besides the structural market drivers, there are strong geographic drivers for the growth of the animal antimicrobials and antibiotics market. The emerging markets are becoming increasingly attractive. The Asian and Latin American region form one of the most promising animal antimicrobials and antibiotics markets in the world. Developing countries such as China and India have a relatively high CAGR rate and are expected to witness significant market growth in the forecast period. The growth in these regions is mainly attributed to the rise in demand for animal protein products, along with an increase in the trend of companion animal ownership in these regions.
Tetracyclines dominated the animal antimicrobials and antibiotics product segment in 2013, accounting for around 60% of the market revenue. This was followed by others segment, which accounted for 16% of the global animal antimicrobials and antibiotics product market in 2013. In the global antimicrobials and antibiotics animal market, pigs dominated the market with a share of close to 25%. In the mode of delivery segment of animal antimicrobials and antibiotics market, premix was the major revenue contributor in 2013, with an estimated share of nearly 49%.
Order a copy of this research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=172326 .
Table of Contents for “Animal Antimicrobials and Antibiotics Market by Products (Tetracyclines, Penicillins, Sulfonamides, Aminoglycosides), Animals (Dog, Poultry, Swine), Mode Of Delivery (Premixes, Oral Powders and Solutions, Injections) - Global Forecasts to 2018” research report include:
1.1 Objectives Of The Study
1.2 Report Description
1. 3 Markets Covered
1.5 Research Methodology
2 Executive Summary
3 Premium Insights
3.1 Growing Consumption Of Animal Protein Products Provides Significant Growth Opportunities For Antimicrobials Market
3.2 Growing Per Capita Companion Animal Heatlh Expenditure To Drive The Market Growth
3.3 Regulatory Ban On Unauthorized Usage Of Antibiotics Curbing The Growth
3.4 High-Growth Potential Of Emerging Markets In Asia-Pacific, MiddleEast, And Latin America
4 Market Overview
4.2 Market Segmentation
4.3 Market Dynamics
4.4 Global Market Share Analysis
5 Veterinary Antimicrobials And Antibiotics Market, By Product
6 Veterinary Antimicrobials And Antibiotics Market, By Mode Of Delivery
6.1.2 Oral Powders & Solutions
6.1.4 Intramammary Preparations
6.1.5 Other Preparations
7 Veterinary Antimicrobials And Antibiotics Market, By Type Of Animal
7.2 Food-Producing Animals
7.2.4 Sheep And Goats
7.3 Companion Animals
7.4 Other Animals
8 Geographic Analysis
8.1.1 North America
220.127.116.11 Rest Of Europe
18.104.22.168 Rest Of Asia-Pacific
8.1.4 Rest Of The World (Row)
22.214.171.124 Latin America
126.96.36.199 Middle East And Africa
9 Competitive Landscape
9.2 Mergers And Acquisitions
9.3 New Product Launches
9.4 Agreements, Collaborations, And Partnerships
10 Company Profiles (Business Overview, Products, Financials, Growth Strategy, Recent Developments, Swot Analysis, & Mnm View)*
10.1 Zoetis, Inc.
10.2 Merck And Co., Inc.
10.3 Bayer Ag
10.4 Virbac Sa
10.5 Eli Lilly And Company
10.6 Boehringer Ingelheim
10.8 Novartis Ag
10.9 Ceva Sante Animale
Priced at US$ 4650 for a single user PDF license, request a discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=172326 .
RnR Market Research library offers syndicated reports by market research publishers from across the globe. We help you find the most relevant business intelligence from ready-to-buy syndicated market research studies. Not limited to industry reports covering telecommunication, healthcare, pharmaceutical, financial services, energy, technology, real estate, logistics, F&B , media and more, RnR Market Research also offers company data, country profiles, trends, information and analysis on the sector of your interest. (http://www.rnrmarketresearch.com/category ).